Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine for postoperative analgesia after laparoscopic surgery in elderly patients
ChiCTR2500110764Phase 4Not yet recruiting
- Sponsor
- Quzhou People's Hospital
- Start
- Oct 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of nalbuphine in acute postoperative pain (2 arms), sponsored by Quzhou People's Hospital. Primary endpoints: VAS pain score at 48 hours and Incidence of hypoxia and hypotension during postoperative recovery at 48 hours. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
nalbuphine
03
Conditions
acute postoperative pain
Beyond the preview
Go deeper on ChiCTR2500110764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500110764.